Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2-metastatic breast cancer

被引：1
作者：
El Rassy, Elie [1 ]
Abdayem, Pamela [1 ]
Kattan, Joseph [1 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Fac Med, Dept Med Oncol, Beirut, Lebanon
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 17期
关键词：
CDK4/6; inhibitor; metastatic breast cancer; mTOR inhibitors; second line; ENDOCRINE THERAPY; SINGLE-ARM; RECEPTOR; TRIAL; EVEROLIMUS; WOMEN;
D O I：
10.2217/fon-2017-0190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1451 / 1453
页数：3
相关论文
共 14 条
  • [1] [Anonymous], INT J CANC CLIN RES
  • [2] Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
    Arpino, Grazia
    Wiechmann, Lisa
    Osborne, C. Kent
    Schiff, Rachel
    [J]. ENDOCRINE REVIEWS, 2008, 29 (02) : 217 - 233
  • [3] Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
    Baselga, Jose
    Campone, Mario
    Piccart, Martine
    Burris, Howard A., III
    Rugo, Hope S.
    Sahmoud, Tarek
    Noguchi, Shinzaburo
    Gnant, Michael
    Pritchard, Kathleen I.
    Lebrun, Fabienne
    Beck, J. Thaddeus
    Ito, Yoshinori
    Yardley, Denise
    Deleu, Ines
    Perez, Alejandra
    Bachelot, Thomas
    Vittori, Luc
    Xu, Zhiying
    Mukhopadhyay, Pabak
    Lebwohl, David
    Hortobagyi, Gabriel N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) : 520 - 529
  • [4] Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial
    Chandarlapaty, Sarat
    Chen, David
    He, Wei
    Sung, Patricia
    Samoila, Aliaksandra
    You, Daoqi
    Bhatt, Trusha
    Patel, Parul
    Voi, Maurizio
    Gnant, Michael
    Hortobagyi, Gabriel
    Baselga, Jose
    Moynahan, Mary Ellen
    [J]. JAMA ONCOLOGY, 2016, 2 (10) : 1310 - 1315
  • [5] Friend S, 2016, MEDICINES, V3, P2
  • [6] Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
    Hortobagyi, G. N.
    Stemmer, S. M.
    Burris, H. A.
    Yap, Y. -S.
    Sonke, G. S.
    Paluch-Shimon, S.
    Campone, M.
    Blackwell, K. L.
    Andre, F.
    Winer, E. P.
    Janni, W.
    Verma, S.
    Conte, P.
    Arteaga, C. L.
    Cameron, D. A.
    Petrakova, K.
    Hart, L. L.
    Villanueva, C.
    Chan, A.
    Jakobsen, E.
    Nusch, A.
    Burdaeva, O.
    Grischke, E. -M.
    Alba, E.
    Wist, E.
    Marschner, N.
    Favret, A. M.
    Yardley, D.
    Bachelot, T.
    Tseng, L. -M.
    Blau, S.
    Xuan, F.
    Souami, F.
    Miller, M.
    Germa, C.
    Hirawat, S.
    O'Shaughnessy, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) : 1738 - 1748
  • [7] Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
    Jerusalem, G.
    Mariani, G.
    Ciruelos, E. M.
    Martin, M.
    Tjan-Heijnen, V. C. G.
    Neven, P.
    Gavila, J. G.
    Michelotti, A.
    Montemurro, F.
    Generali, D.
    Simoncini, E.
    Lang, I.
    Mardiak, J.
    Naume, B.
    Camozzi, M.
    Lorizzo, K.
    Bianchetti, S.
    Conte, P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (09) : 1719 - 1725
  • [8] Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR1/HER2-Advanced Breast Cancer
    Pritchard, Kathleen I.
    Chia, Stephen K.
    Simmons, Christine
    McLeod, Deanna
    Paterson, Alexander
    Provencher, Louise
    Rayson, Daniel
    [J]. ONCOLOGIST, 2017, 22 (01) : 12 - 24
  • [9] Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial
    Rugo, Hope S.
    Seneviratne, Lasika
    Beck, J. Thaddeus
    Glaspy, John A.
    Peguero, Julio A.
    Pluard, Timothy J.
    Dhillon, Navneet
    Hwang, Leon Christopher
    Nangia, Chaitali
    Mayer, Ingrid A.
    Meiller, Timothy F.
    Chambers, Mark S.
    Sweetman, Robert W.
    Sabo, J. Randy
    Litton, Jennifer K.
    [J]. LANCET ONCOLOGY, 2017, 18 (05) : 654 - 662
  • [10] Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
    Rugo, Hope S.
    Rumble, R. Bryan
    Macrae, Erin
    Barton, Debra L.
    Connolly, Hannah Klein
    Dickler, Maura N.
    Fallowfield, Lesley
    Fowble, Barbara
    Ingle, James N.
    Jahanzeb, Mohammad
    Johnston, Stephen R. D.
    Korde, Larissa A.
    Khatcheressian, James L.
    Mehta, Rita S.
    Muss, Hyman B.
    Burstein, Harold J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 3069 - +
12